Biomedical Engineering Reference
In-Depth Information
9. T. Kato and T. Hamanaka. Ocular signs and symp-
toms caused by exposure to sarin gas. Am J
Ophthalmol
121:209-210, 1996.
10. A. P. Volans. Sarin: guidelines on the management
of victims of a nerve gas attack.
J Accid Emerg
Med
13:202-206, 1996.
11. F. Dicenta, P. Martinez-Gomez, N. Grane,
et al. Relationship between cyanogenic compounds
in kernels, leaves, and roots of sweet and
bitter kernelled almonds.
J Agric Food Chem
50:2149-2152, 2002.
12. D. D. Ngudi, Y. H. Kuo, and F. Lambein. Cassava
cyanogens and free amino acids in raw and cooked
leaves.
Food Chem Toxicol
41:1193-1197, 2003.
13. T. Okumura, N. Ninomiya, and M. Ohta. The chem-
ical disaster response system in Japan.
Prehospital
Disaster Med
18:189-192, 2003.
14. D. W. Walsh and M. Eckstein. Hydrogen cyanide
in fire smoke: an underappreciated threat.
Emerg
Med Serv
33:160-163, 2004.
15. A. P. Morocco. Cyanides.
Crit Care Clin
21:691-705, vi, 2005.
16. R. Gracia and G. Shepherd. Cyanide poisoning
and its treatment.
Pharmacotherapy
24:1358-
1365, 2004.
17. H. Kerger, P. Dodidou, D. Passani-Kruppa, et al.
Excessive methaemoglobinaemia and multi-organ
failure following 4-DMAP antidote therapy.
Resus-
citation
66:231-235, 2005.
18. D. M. Beasley and W. I. Glass. Cyanide poisoning:
pathophysiology and treatment recommendations.
Occup Med (Lond)
48:427-431, 1998.
19. M. Balali-Mood and M. Hefazi. The pharma-
cology, toxicology, and medical treatment of
sulphur mustard poisoning.
Fundam Clin Phar-
macol
19:297-315, 2005.
20. J. McManus and K. Huebner. Vesicants.
Crit Care
Clin
21:707-718, vi, 2005.
21. K. Kehe and L. Szinicz. Medical aspects of sulphur
mustard
poisoning.
Toxicology
214:198-209,
2005.
22. K. J. Smith, C. G. Hurst, R. B. Moeller, et al.
Sulfur mustard: its continuing threat as a chem-
ical warfare agent, the cutaneous lesions induced,
progress in understanding its mechanism of action,
its long-term health effects, and new developments
for protection and therapy.
J Am Acad Dermatol
32:765-776, 1995.
23. S. Khateri, M. Ghanei, S. Keshavarz, et al. Inci-
dence of lung, eye, and skin lesions as late
complications in 34,000 Iranians with wartime
exposure to mustard agent.
J Occup Environ Med
45:1136-1143, 2003.
24. Y. Solberg, M. Alcalay, and M. Belkin.
Ocular injury by mustard gas.
Surv Ophthalmol
41:461-466, 1997.
25. M. Hefazi, D. Attaran, M. Mahmoudi, and
M. Balali-Mood. Late respiratory complications of
mustard gas poisoning in Iranian veterans.
Inhal
Toxicol
17:587-592, 2005.
Suggested Comprehensive Resources
Office of the Surgeon General, United States Army.
Medical Aspects of Chemical and Biological
Warfare.
Textbook of Military Medicine
(B. G. Russ
Zajtchuk, ed.). 1997.
Field Management of Chemical Casualties Handbook
.
2nd edition. Chemical Casualty Care Division,
USAMRICD, MCMR-UV-ZM, 3100 Ricketts Point
Rd., Aberdeen Proving Ground, MD 21010-5400,
July 2000.
